2 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Cardeas Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers amikacin/fosfomycin - Healthy | Phase 1 | Completed | Cardeas Pharma | 30 | 2016-04-01 | 2016-07-11 |
| Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization Amikacin Fosfomycin Inhalation Solution, Aerosolized placebo - Pneumonia, Bacterial | Phase 2 | Withdrawn | Cardeas Pharma | 2014-10-01 | 2015-11-18 | |
| Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia Amikacin fosfomycin inhalation solution, Aerosolized placebo - Pneumonia, Bacterial | Phase 2 | Completed | Cardeas Pharma | 143 | 2013-12-01 | 2017-07-02 |
Bacterial Infections (2) · Lung Diseases (2) · Pneumonia (2) · Pneumonia, Bacterial (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
Amikacin (1) · Fosfomycin (1)
United States (2) · France (1) · Greece (1) · Hungary (1) · Puerto Rico (1) · Spain (1) · Turkey (Türkiye) (1)
Bruce Montgomery, M.D. (1) · Marin Kollef, M.D. (1)